Exact Sciences Corporation (EXAS)
Interview with: Don Hardison, President and CEO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their genomics-based PreGen-Plus(TM)
for screening for colorectal cancer in the average-risk population. |
![](CDItel2.gif)
Cover Story
CEOCFO
Interview Index
CEOCFO
Current Issue
Cover Story
Archives
Future Features
Analyst Interviews
Corporate
Financials
Archived Interviews
About CEOCFOinterviews.com
Contact
& Ordering |
This is a printer friendly page!
With
most people being inadequately tested or not tested at all Exact Sciences is going after
the colorectal cancer market with a non-invasive test for early detection
![wpe63.jpg (4290 bytes)](ExactS1.jpg)
Healthcare
Biotechnology and Drugs
(EXAS-NASD)
Exact Sciences Corporation
![wpe65.jpg (10298 bytes)](ExactS2.jpg)
Don Hardison
President and CEO
Interview conducted by:
Lynn Fosse
Senior Editor
CEOCFOinterviews.com
July 2004
disclaimers
Any reproduction or further distribution of this
article without the express written consent of CEOCFOinterviews.com is prohibited.
|